// App-Quantinova.ai

: Clinical correlation of circulating tumor cell (CTC) PD-L1 and HLA I expression in metastatic renal cell carcinoma (mRCC) using exclusion-based sample preparation technology.

Researchers

Presenter

  • Hamid Emamekhoo

Principal Investigators

  • Jennifer L. Schehr

  • Rory M. Bade

  • Xiao X. Wei

  • Rana R. McKay

  • Toni K. Choueiri

  • Joshua Michael Lang

Medical Centers

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Department of Medical Physics, University of Wisconsin, Madison, WI

  • University of Wisconsin Comprehensive Cancer Center, Madison, WI

  • Dana-Farber Cancer Institute, Boston, MA

  • Moores Cancer Center, University of California, San Diego, La Jolla, CA

  • Dana-Farber Cancer Institute/Brigham and Women’s Hospital and Harvard University School of Medicine, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Metastatic Renal Cell Cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Programmed death-ligand 1

  • Epithelial Cell Adhesion Molecule

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved